National AIDS Memorial Receives $2.4 Million Donation From Gilead Sciences to Support the AIDS Memorial Quilt as It Moves Home to San Francisco
Today, the National AIDS Memorial and Gilead Sciences, Inc. (Nasdaq: GILD) announced a $2.4 million donation from Gilead to support The AIDS Memorial Quilt (The Quilt), its public education programs and its relocation to San Francisco under the stewardship of the National AIDS Memorial.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191127005622/en/
The grant will provide important resources as the National AIDS Memorial works with The NAMES Project Foundation (NPF) to move more than 50,000 individual memorial panels of The Quilt from Atlanta to San Francisco, where it will permanently reside. The grant will also support The Quilt programs, which include displays, panel making and conservation, and a new educational initiative that will be launched in 2020 to help reach communities and populations adversely impacted by HIV through the symbolism of The Quilt.
“Gilead has had a tremendous impact as a scientific leader in the development of therapeutic treatments for HIV/AIDS and, through its philanthropic efforts, has made a difference for causes and in communities impacted by the disease,” said John Cunningham, Executive Director of the National AIDS Memorial. “This grant will provide important resources to the National AIDS Memorial in support of The Quilt moving to San Francisco, its programs and new educational efforts to reach communities that are disproportionately impacted by HIV.”
Earlier this month, NPF announced that The Quilt and its programs will relocate to the National AIDS Memorial in early 2020, becoming an integral part of its mission to provide, in perpetuity, a place of remembrance so that the lives of people who died from AIDS-related complications are not forgotten and that their stories are known and understood by future generations.
Each year, thousands of The Quilt panels are displayed throughout the United States and the world, serving as a memorial, a storyteller and an educator. It has been a powerful symbol to fight prejudice, raise awareness, link hands with the global community in the fight against AIDS, promote healing and foster hope through education and prevention.
Gilead’s philanthropic efforts are focused on supporting communities that are disproportionately impacted by disease, enhancing access and advancing education efforts like that of The Quilt to continue to raise awareness of the epidemic.
“Gilead is honored to support The Quilt, which is a national treasure and a poignant tribute to those who lost their lives to HIV/AIDS,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead Sciences. “We are proud to be a long-standing partner to the National AIDS Memorial, supporting its work to educate and inspire a new generation of advocates in the fight to end the epidemic.”
The Quilt is an extraordinary piece of history, art, activism and hope. Thirty-two years ago during the height of the AIDS epidemic, a group of strangers gathered at a San Francisco storefront to remember the names and lives of loved ones they feared history would forget – and with that seemingly simple act of love and defiance, the first panels of The Quilt were created. Three years later and just a few miles away in Golden Gate Park, another small group of San Franciscans, also representing a community devastated by the AIDS epidemic, gathered in a dilapidated grove in Golden Gate Park to restore it and create a serene place where people seeking healing could gather to express their collective grief through a living AIDS memorial, which is now known as the National AIDS Memorial.
The Quilt was conceived by long-time San Francisco gay rights activist Cleve Jones. Since the 1978 assassinations of gay San Francisco Supervisor Harvey Milk and Mayor George Moscone, Jones had helped organize an annual candlelight march honoring these men. While planning the 1985 march, he learned that more than 1,000 San Franciscans had been lost to AIDS. He asked each of his fellow marchers to write on placards the names of friends and loved ones who had died of AIDS-related complications. At the end of the march, Jones and others stood on ladders taping these placards to the walls of the San Francisco Federal Building. The wall of names looked like a patchwork quilt.
Inspired by this sight, Jones and friends made plans for a larger memorial. A little over a year later, he created the first panel for the AIDS Memorial Quilt in memory of his friend Marvin Feldman. In June of 1987, Jones teamed up with Mike Smith and several others to formally organize the NAMES Project Foundation. Generous donors rapidly supplied sewing machines, equipment and other materials, and many volunteered tirelessly. At the 1987 National March for Lesbian and Gay Rights in Washington, D.C., the Quilt contained more than 1,900 commemorative fabric panels. The Quilt, sewn together by friends, lovers and family members, now contains more than 50,000 panels, weighs more than 54 tons and commemorates more than 105,000 individual lives of people who have died of AIDS-related complications.
Today, The Quilt is a visual reminder of the AIDS pandemic and continues as the largest ongoing community art project in the world. There are more than 1.1 million people currently living with HIV in the United States, with more than 15,000 people having died of AIDS-related complications in 2017 alone. In 2016, more than 38,000 people received an HIV diagnosis, with half of those living in the South, and Black/African American gay and bisexual men accounting for the largest number of HIV diagnoses.
About the National AIDS Memorial
The National AIDS Memorial relies solely on funding from longtime personal donors and corporate partners to support its mission as a dedicated space in the national landscape where millions of Americans touched directly or indirectly by AIDS can gather to heal, hope, and remember. The National AIDS Memorial, known as “the Grove”, was created more than twenty-eight years ago in San Francisco’s Golden Gate Park at the height of the HIV/AIDS epidemic as a place where those impacted by AIDS could both grieve and begin the process of healing. In 1996, legislation sponsored by U.S. Representative Nancy Pelosi was signed into law by President Clinton that elevated “the Grove” as this nation's sole federally-designated National AIDS Memorial. More than 50,000 individuals from around the world have contributed 225,000 volunteer hours to support the National AIDS Memorial and its mission. For more information visit www.aidsmemorial.org.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
For more than 30 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention, testing and linkage to care, and cure research. Today, it is estimated that more than 12 million people living with HIV globally receive antiretroviral therapy provided by Gilead or one of the company’s manufacturing partners.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
National AIDS Memorial
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EET | Press release
HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop
Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EET | Press release
Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities
Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EET | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator
HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EET | Press release
HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EET | Press release
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom